search
Back to results

Ginsenoside Improve Metabolic Syndrome

Primary Purpose

Metabolic Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Ginsenoside
Dietary fiber fill
Sponsored by
CHA University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Metabolic Syndrome

Eligibility Criteria

40 Years - 80 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • metabolic syndrome

Exclusion Criteria:

  • Taking drug for lipid-lowering, BP control and anti-diabetic.

Sites / Locations

  • Bundang CHA Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Ginsenoside

Dietary fiber fill

Arm Description

Ginsenoside : Intervention : ginsenoside, 3 gram / day, for 28 days in intervention group

Dietary fiber fill manufactured to mimic Ginsenoside tablet

Outcomes

Primary Outcome Measures

Change from baseline in metabolic syndrome profile at week 4
Total cholesterol, HDL-Cholesterol, Glucose, Blood Pressure, Body weight

Secondary Outcome Measures

Change from baseline in hormones at week 4.
insulin ,cortisol, testosterone, somatomedin-c and DHEAS

Full Information

First Posted
July 21, 2013
Last Updated
January 10, 2014
Sponsor
CHA University
Collaborators
The Korean Society of Ginseng
search

1. Study Identification

Unique Protocol Identification Number
NCT02034136
Brief Title
Ginsenoside Improve Metabolic Syndrome
Official Title
Effects of Ginsenoside Supplementation on Insulin Resistance and Cardiometabolic Risk Factors in Men With Metabolic Syndrome: a Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2014
Overall Recruitment Status
Unknown status
Study Start Date
February 2014 (undefined)
Primary Completion Date
September 2014 (Anticipated)
Study Completion Date
December 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
CHA University
Collaborators
The Korean Society of Ginseng

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Aim : Investigated the effects of Korean red ginseng supplementation on metabolic parameters such as cholesterol, blood pressure and glucose. Randomized Control Trial.
Detailed Description
Methods : A randomized, double-blind, placebo-controlled, single-center study in 60 subjects who are not taking drugs that could affect metabolic and vascular function. Subjects will be randomized into a Korean red ginseng (3.0g/d) group or placebo group for a 4-week study. We will collect anthropometric measurements, blood for laboratory testing, inflammatory marker, hormones and mitochondrial DNA copy number. Subject : Older than 40 years of age, presented with metabolic syndrome. Subjects were excluded if they were taking drugs that could affect metabolic and vascular function, including BP control drug, anti-diabetic drugs and lipid-lowering drugs. Measurement : We will collect anthropometric measurements and blood for laboratory testing at the initial(week 0) and final (week 4)visits. Serum levels of blood glucose, insulin, total cholesterol, HDL-cholesterol,triglyceride, and DNA copy number of mitochondria.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Ginsenoside
Arm Type
Experimental
Arm Description
Ginsenoside : Intervention : ginsenoside, 3 gram / day, for 28 days in intervention group
Arm Title
Dietary fiber fill
Arm Type
Placebo Comparator
Arm Description
Dietary fiber fill manufactured to mimic Ginsenoside tablet
Intervention Type
Dietary Supplement
Intervention Name(s)
Ginsenoside
Other Intervention Name(s)
Ginseng fill
Intervention Description
3.0 g/ d for 28 days
Intervention Type
Dietary Supplement
Intervention Name(s)
Dietary fiber fill
Intervention Description
3g/day, 28days
Primary Outcome Measure Information:
Title
Change from baseline in metabolic syndrome profile at week 4
Description
Total cholesterol, HDL-Cholesterol, Glucose, Blood Pressure, Body weight
Time Frame
Baseline and 4 weeks from intake of Ginsenoside
Secondary Outcome Measure Information:
Title
Change from baseline in hormones at week 4.
Description
insulin ,cortisol, testosterone, somatomedin-c and DHEAS
Time Frame
Initial and 4 weeks later
Other Pre-specified Outcome Measures:
Title
Mitochondria DNA copy number
Time Frame
initial and 4 weeks later

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: metabolic syndrome Exclusion Criteria: Taking drug for lipid-lowering, BP control and anti-diabetic.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
DH Jung, MPH
Phone
+82) 10-4204-8998
Email
balsan2@empas.com
First Name & Middle Initial & Last Name or Official Title & Degree
YJ Lee, Ph.D
Phone
+82) 3015-2011
Email
ykyjhome@yuhs.ac
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
DH Jung, MPH.M.D.
Organizational Affiliation
Cha Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bundang CHA Hospital
City
Seoul
State/Province
Kyeonggi-do
Country
Korea, Republic of
Facility Contact:
First Name & Middle Initial & Last Name & Degree
HG Park, PhD
Email
irb@chamc.co.kr
First Name & Middle Initial & Last Name & Degree
DH Jung, MPH

12. IPD Sharing Statement

Citations:
PubMed Identifier
22916320
Citation
Park BJ, Lee YJ, Lee HR, Jung DH, Na HY, Kim HB, Shim JY. Effects of Korean Red Ginseng on Cardiovascular Risks in Subjects with Metabolic Syndrome: a Double-blind Randomized Controlled Study. Korean J Fam Med. 2012 Jul;33(4):190-6. doi: 10.4082/kjfm.2012.33.4.190. Epub 2012 Jul 25.
Results Reference
background
PubMed Identifier
18339495
Citation
Rasheed N, Tyagi E, Ahmad A, Siripurapu KB, Lahiri S, Shukla R, Palit G. Involvement of monoamines and proinflammatory cytokines in mediating the anti-stress effects of Panax quinquefolium. J Ethnopharmacol. 2008 May 8;117(2):257-62. doi: 10.1016/j.jep.2008.01.035. Epub 2008 Feb 8.
Results Reference
background
PubMed Identifier
23089630
Citation
Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry. 2013 Jun;18(6):692-9. doi: 10.1038/mp.2012.144. Epub 2012 Oct 23.
Results Reference
background
PubMed Identifier
17615678
Citation
Yun SN, Ko SK, Lee KH, Chung SH. Vinegar-processed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice. Arch Pharm Res. 2007 May;30(5):587-95. doi: 10.1007/BF02977653.
Results Reference
background
PubMed Identifier
22589267
Citation
Kim JH, Lee DC. Mitochondrial DNA copy number in peripheral blood is associated with femoral neck bone mineral density in postmenopausal women. J Rheumatol. 2012 Jul;39(7):1465-72. doi: 10.3899/jrheum.111444. Epub 2012 May 15.
Results Reference
background
PubMed Identifier
26860800
Citation
Jung DH, Lee YJ, Kim CB, Kim JY, Shin SH, Park JK. Effects of ginseng on peripheral blood mitochondrial DNA copy number and hormones in men with metabolic syndrome: A randomized clinical and pilot study. Complement Ther Med. 2016 Feb;24:40-6. doi: 10.1016/j.ctim.2015.12.001. Epub 2015 Dec 4.
Results Reference
derived
Links:
URL
http://www.ginsengsociety.org/
Description
The goal of Korean ginsengsociety is to help elevate the level of ginseng science in both theory and practice by providing technical information to the ginseng industry, providing ginseng-related education to the community.

Learn more about this trial

Ginsenoside Improve Metabolic Syndrome

We'll reach out to this number within 24 hrs